Minerva Surgical Revenue 2021-2023 | UTRS
Minerva Surgical revenue from 2021 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Minerva Surgical Annual Revenue (Millions of US $) |
|
|---|---|
| 2022 | $50 |
| 2021 | $52 |
| 2020 | $38 |
| Minerva Surgical Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-09-30 | $12 |
| 2023-06-30 | $13 |
| 2023-03-31 | $13 |
| 2022-12-31 | $14 |
| 2022-09-30 | $13 |
| 2022-06-30 | $13 |
| 2022-03-31 | $11 |
| 2021-12-31 | $14 |
| 2021-09-30 | $13 |
| 2021-06-30 | $14 |
| 2021-03-31 | $12 |
| 2020-12-31 | |
| 2020-09-30 | $12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.050B |
| Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. Minerva Surgical is based in SANTA CLARA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.939B | 23.69 |
| Stryker (SYK) | United States | $123.542B | 29.59 |
| Medtronic (MDT) | Ireland | $111.935B | 15.85 |
| Boston Scientific (BSX) | United States | $107.817B | 34.34 |
| EssilorLuxottica (ESLOY) | France | $101.153B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.922B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.990B | 27.73 |
| ResMed (RMD) | United States | $31.710B | 29.77 |
| Terumo (TRUMY) | Japan | $25.565B | 36.10 |
| Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.681B | 15.77 |
| Baxter (BAX) | United States | $17.958B | 12.77 |
| Insulet (PODD) | United States | $12.066B | 53.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.266B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.385B | 27.43 |
| BellRing Brands (BRBR) | United States | $7.844B | 36.74 |
| Lantheus Holdings (LNTH) | United States | $5.455B | 13.59 |
| Haemonetics (HAE) | United States | $4.945B | 24.47 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.129B | 12.52 |
| Prestige Consumer Healthcare (PBH) | United States | $3.548B | 16.98 |
| Envista Holdings (NVST) | United States | $3.295B | 13.60 |
| QuidelOrtho (QDEL) | United States | $2.959B | 16.42 |
| Neogen (NEOG) | United States | $2.835B | 27.27 |
| TG Therapeutics (TGTX) | United States | $2.776B | 78.09 |
| Green Thumb Industries (GTBIF) | United States | $2.714B | 53.75 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.690B | 0.00 |
| ICU Medical (ICUI) | United States | $2.565B | 22.63 |
| Agios Pharmaceuticals (AGIO) | United States | $1.938B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.927B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.34 |
| InMode (INMD) | Israel | $1.560B | 8.29 |
| Warby Parker (WRBY) | United States | $1.543B | 0.00 |
| Owens & Minor (OMI) | United States | $1.513B | 13.19 |
| AdaptHealth (AHCO) | United States | $1.306B | 9.73 |
| National Vision Holdings (EYE) | United States | $1.200B | 38.20 |
| AtriCure (ATRC) | United States | $1.042B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.032B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.983B | 0.00 |
| Evolus (EOLS) | United States | $0.799B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.738B | 15.70 |
| Cresco Labs (CRLBF) | United States | $0.698B | 0.00 |
| Quanterix (QTRX) | United States | $0.644B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.631B | 14.83 |
| PetIQ (PETQ) | United States | $0.576B | 18.82 |
| Valneva SE (VALN) | France | $0.558B | 0.00 |
| Jin Medical (ZJYL) | China | $0.522B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
| Surmodics (SRDX) | United States | $0.471B | 29.46 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.443B | 8.50 |
| OraSure Technologies (OSUR) | United States | $0.403B | 12.98 |
| Aurora Cannabis (ACB) | Canada | $0.382B | 0.00 |
| Cerus (CERS) | United States | $0.377B | 0.00 |
| Zynex (ZYXI) | United States | $0.345B | 47.22 |
| MacroGenics (MGNX) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 25.77 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.197B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.164B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.152B | 73.06 |
| InterCure (INCR) | Israel | $0.148B | 24.96 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.36 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 8.94 |
| Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.090B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.067B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.96 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.08 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |